Update on diagnosis and treatment of multiple sclerosis

被引:1
作者
Depaz, R. [1 ]
Aboab, J. [1 ]
Gout, O. [1 ]
机构
[1] Fondat Ophtalmol Adolphe de Rothschild, F-75019 Paris, France
来源
REVUE DE MEDECINE INTERNE | 2013年 / 34卷 / 10期
关键词
Multiple sclerosis; Neuroimaging; Diagnosis; Treatment; LONGITUDINAL FOLLOW-UP; NATURAL-HISTORY; INTERFERON-BETA; GLATIRAMER ACETATE; INTRAMUSCULAR INTERFERON; CORTICAL DEMYELINATION; DISEASE-ACTIVITY; DISABILITY; MRI; NATALIZUMAB;
D O I
10.1016/j.revmed.2013.02.011
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Recent advances in neuroimaging have simplified the diagnostic criteria of multiple sclerosis. Indeed, the diagnosis of multiple sclerosis could be obtained during the first bout of disease flare, very early in the disease course. This is particularly important to shorten the diagnostic delay as early treatment may limit the occurrence of late irreversible disabilities. At the same time, major therapeutic advances have been obtained and new drugs that are well tolerated and more effective, despite the possible rare but potentially severe side effects are been developed. This article reviews the modern diagnostic and therapeutic strategies in multiple sclerosis in accordance with the recent obtained advances. (C) 2013 Published by Elsevier Masson SAS on behalf of the Societe nationale francaise de medecine interne (SNFMI).
引用
收藏
页码:628 / 635
页数:8
相关论文
共 60 条
  • [1] Longitudinal follow-up of "benign" multiple sclerosis at 20 years
    Amato, Maria Pia
    De Stefano, Nicola
    [J]. NEUROLOGY, 2007, 69 (09) : 938 - 938
  • [2] What is the risk of permanent disability from a multiple sclerosis relapse?
    Bejaoui, Khemissa
    Rolak, Loren A.
    [J]. NEUROLOGY, 2010, 74 (11) : 900 - 902
  • [3] Risk of Natalizumab-Associated Progressive Multifocal Leukoencephalopathy
    Bloomgren, Gary
    Richman, Sandra
    Hotermans, Christophe
    Subramanyam, Meena
    Goelz, Susan
    Natarajan, Amy
    Lee, Sophia
    Plavina, Tatiana
    Scanlon, James V.
    Sandrock, Alfred
    Bozic, Carmen
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2012, 366 (20) : 1870 - 1880
  • [4] Intense immunosuppression in patients with rapidly worsening multiple sclerosis: treatment guidelines for the clinician
    Boster, Aaron
    Edon, Gilles
    Frohman, Elliott
    Javed, Adii
    Stuve, Olaf
    Tselis, Alexandros
    Weiner, Howard
    Weinstock-Guttman, Bianca
    Khan, Omar
    [J]. LANCET NEUROLOGY, 2008, 7 (02) : 173 - 183
  • [5] Brodsky M, 2008, ARCH NEUROL-CHICAGO, V65, P727, DOI 10.1001/archneur.65.6.727
  • [6] Reduced brain functional reserve and altered functional connectivity in patients with multiple sclerosis
    Cader, S
    Cifelli, A
    Abu-Omar, Y
    Palace, J
    Matthews, PM
    [J]. BRAIN, 2006, 129 : 527 - 537
  • [7] MRI and the diagnosis of multiple sclerosis: expanding the concept of "no better explanation"
    Charil, Arnaud
    Yousry, Tarek A.
    Rovaris, Marco
    Barkhof, Frederik
    De Stefano, Nicola
    Fazekas, Franz
    Miller, David H.
    Montalban, Xavier
    Simon, Jack H.
    Polman, Chris
    Filippi, Massimo
    [J]. LANCET NEUROLOGY, 2006, 5 (10) : 841 - 852
  • [8] Oral Fingolimod or Intramuscular Interferon for Relapsing Multiple Sclerosis
    Cohen, Jeffrey A.
    Barkhof, Frederik
    Comi, Giancarlo
    Hartung, Hans-Peter
    Khatri, Bhupendra O.
    Montalban, Xavier
    Pelletier, Jean
    Capra, Ruggero
    Gallo, Paolo
    Izquierdo, Guillermo
    Tiel-Wilck, Klaus
    de Vera, Ana
    Jin, James
    Stites, Tracy
    Wu, Stacy
    Aradhye, Shreeram
    Kappos, Ludwig
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2010, 362 (05) : 402 - 415
  • [9] Coles AJ, 2008, NEW ENGL J MED, V359, P1786, DOI 10.1056/NEJMoa0802670
  • [10] Multiple sclerosis
    Compston, Alastair
    Coles, Alasdair
    [J]. LANCET, 2008, 372 (9648) : 1502 - 1517